MannKind is acquiring DKI portfolio position scPharmaceuticals ($SCPH) for $5.35/share in cash plus a contingent value right (CVR) worth up to $1.00/share. The full value represents a 31% premium to Friday’s closing price. MannKind has the necessary financing from Blackstone. This is the second DKI healthcare device portfolio company acquired in the past two ... Read more The post scPharmaceuticals ($SCPH) – Being Acquired by MannKind for a Large Premium appeared first on Deep Knowledg...
